Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Dozens of prepared foods, vegetable plates and sushi are being recalled for containing cucumbers linked to 26 cases of Salmonella poisoning.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Dominik Scheffer, chief sales officer at M Food Group, highlights the company’s new starter cultures for fermented products, ...

At current levels, we believe AMGN scores above BMY, buoyed by solid fundamentals and recent positive estimate revisions.

Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total ...

Prothena has already discontinued the development of birtamimab, and anticipates further spending cuts, including workforce ...

We speak with Woody Lau, senior sales manager for DACH & Nordic, European Division at Angel Yeast, about the company’s latest yeast and protein products for the bakery sector. We discuss clean-label ...

Typically, the goal of ALS treatments is to slow the disease or halt progression. But new data from the antisense oligonucleotide (ASO) jacifusen for FUS-ALS show that two patients went beyond the ...

Azafaros has secured 132 million euros ($147 million) in series B funds that the Dutch biotech will use to push its rare neurological disease drug through two late-stage trials.

IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...